Hauser Issues Correction to Company Description
13. März 2003 16:15 ET
|
Hauser, Inc.
EL SEGUNDO, Calif., and LONGMONT, Colo., March 13, 2003 (PRIMEZONE) -- Hauser, Inc. (OTCBB:HAUS) today said that, in the company description of its fiscal 2003 third quarter news release dated...
Amersham Health Expands Imanet with Addition of Finland's World-leading PET Centre
03. März 2003 02:24 ET
|
Amersham plc
LONDON, March 3, 2003 (PRIMEZONE) -- Amersham Health, the global leader in medical diagnostic imaging and a business of Amersham plc (LSE:AHM) (NYSE:AHM) (Oslo:AHM) today announced that Finland's...
Pharmexa Focuses and Adjusts the Organization
29. Januar 2003 05:26 ET
|
Pharmexa A/S
HOERSHOLM, Denmark, Jan. 29, 2003 (PRIMEZONE) -- As first announced on September 10, 2002, Pharmexa (Other OTC:PMXAY) is increasingly focusing its resources on the most advanced products, the HER-2...
Novartis to Unite Its Generics Businesses Under One Single Global Brand: Sandoz
21. Januar 2003 05:05 ET
|
Novartis
BASEL, Switzerland and KUNDL, Austria, Jan. 21, 2002 (PRIMEZONE) -- Novartis (NYSE:NVS) today unveiled plans to unite its 14 Generics company brands under a single global umbrella name, "Sandoz," to...
Positive Results for Medivir's Project MIV-210 Presented at ICAAC
30. September 2002 04:12 ET
|
Medivir
HUDDINGE, Sweden, Sept. 30, 2002 (PRIMEZONE) -- Medivir's (Stockholm:MVIRb) antiviral MIV-210 is active against HIV and HBV (hepatitis B virus, viral jaundice) and is in phase I clinical trials. The...
Akzo Nobel Divests Rosemont Pharmaceuticals
20. September 2002 06:06 ET
|
Akzo Nobel
ARNHEM, The Netherlands, Sept. 20, 2002 (PRIMEZONE) -- Akzo Nobel (Nasdaq:AKZOY) has divested Rosemont Pharmaceuticals Ltd. of Leeds, United Kingdom, its liquid pharmaceuticals manufacturing business...
atugen Announces New Collaboration with Schering AG, Germany
17. September 2002 02:14 ET
|
atugen AG
BERLIN, Germany, Sept. 17, 2002 (PRIMEZONE) -- atugen AG today announced a new collaboration with Schering AG (Frankfurt:SCHG) (NYSE:SHR) to validate a number of novel drug targets associated with...
Aventis Pharmaceuticals Makes Milestone Payment to Astex
04. September 2002 03:20 ET
|
Astex Therapeutics
CAMBRIDGE, U.K., Sept. 4, 2002 (PRIMEZONE) -- Astex Technology, the structure-based drug discovery company, today announced that it has received the first milestone payment from Aventis...
Pharmexa A/S: Interim Report for the First 6 Months of the Financial Year 2002
21. August 2002 07:04 ET
|
Pharmexa A/S
HORSHOLM, Denmark, Aug. 21, 2002 (PRIMEZONE) -- The Pharmexa Group had turnover of kDKK 8,123 in the first 6 months of 2002 and realized a net loss of kDKK 75,519. Research and Development costs...
BioCurex Secures New European Distributor for Its Diagnostic Cancer Kits
24. Juli 2002 05:00 ET
|
BioCurex, Inc.
RANCHO SANTA MARGARITA, Calif., July 24, 2002 (PRIMEZONE) - BioCurex (OTCBB:BOCX) announces another important distribution deal for its novel cancer diagnostic kits. P2000 Comercializacao de...